Are antidepressants addictive?

Drug and Alcohol Review

Volumn 21, Issue 4, 2002, Pages 317-319

  Dean, Angela J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADDICTION; EDITORIAL; HUMAN; PSYCHOLOGICAL ASPECT; WITHDRAWAL SYNDROME;

ANTIDEPRESSIVE AGENTS; BEHAVIOR, ADDICTIVE; HUMANS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036903446     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/0959523021000037590     Document Type: Editorial

References (24)

1. Olfson M., Marcus S.C., Pincus H.A., Zito J.M., Thompson J.W., Zarin D.A. Antidepressant prescribing practices of out-patient psychiatrists. Arch Gen Psychiatry 1998;55: 310-16.
2. Zohar J., Westenberg H.G.M. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors Acta Psychiatr Scand 2000;101(Suppl 403); 39-49.
3. Priest R.G., Vize C., Roberts A., Roberts M., Tylee A. Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. Br Med J 1996;313:858-9.
4. Lejoyeux M., Ades J. Antidepressant discontinuation: a review of the literature. J Clin Psychiatry 1997;58(Suppl 7):11-16.
5. Schatzberg A.F., Haddad P., Kaplan E.M., et al. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. J Clin Psychiatry 1997;58(Suppl 7):5-10.
6. Rosenbaum J.F., Fava M., Hoog S.L., Ascroft R.C., Krebs W.B. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 1998; 44:77-87.
7. Dean A.J., Moses G.M., Vernon J. Suspected withdrawal syndrome after cessation of St John's Wort. Ann Pharmacother, in press.
8. Schatzberg A.F., Haddad P., Kaplan E.M., et al. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. J Clin Psychiatry 1997; 58(Suppl 7):23-27.
9. Dilsaver S.C. Withdrawal phenomena associated with anti-depressant and antipsychotic agents. Drug Safety 1994;10: 103-14.
10. Whittal M.L., Otto M.W., Hong J.J. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series. Behav Res Ther 2001;39:939-45.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association 1994.
12. Haddad P. Do antidepressants have any potential to cause addiction? J Psychopharmacol 1999;13:300-7.
13. Medawar C. The antidepressant web: marketing depression and making medicines work. Int J Risk Safety Med 1997;10: 75-126.
14. Donoghue J., Hylan T.R. Antidepressant use in clinical practice: efficacy versus effectiveness. Br J Psychiatry 2001; 179(Suppl 42):S9-17.
15. 2c receptors in the control of central dopamine function. TiPS 2001;5:229-32.
16. D'Aquila P.S., Collu P., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 2000;405:365-73.
17. Lee K., Kornetsky C. Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation. Pharmacol Biochem Behav 1998;60: 539-44.
18. Ichikawa J., Kuroki T., Meltzer H.Y. Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens. Eur J Pharmacol 1998;350:159-64.
19. Zangen A., Nakash R., Overstreet D.H., Yadid G. Association between depressive behaviour and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology 2001;155:434-9.
20. Tremblay L.K., Naranjo C.A., Cardenas L., Herrman N., Busto U.E. Probing brain reward system function in major depressive disorder. Arch Gen Psychiatry 2002;59:409-16.
21. Hyman S.E., Nestler E.J. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996;153:151-2.
22. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54: 597-606.
23. Mayberg H.S., Brannan S.K., Tekell J.L., et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830-43.
24. Sartorius N. The economic and social burden of depression. J Clin Psychiatry 200;162(Suppl 15):8-11.